Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-06-16
2010-10-26
Saunders, David A (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S177100, C530S413000
Reexamination Certificate
active
07820799
ABSTRACT:
The present application provides methods of purifying polypeptides having a Fc region, for example, antibodies or antibody fusions, by adsorbing the polypeptides to a Fc binding agent, such as, for example, Protein A or Protein G, followed by a wash with a divalent cation salt buffer to remove impurities and subsequent recovery of the adsorbed polypeptides. The present application also features methods of eluting the purified polypeptide as well as the incorporation of the methods within a purification train. Kits comprising components for carrying out the methods and instructions for use are also provided.
REFERENCES:
patent: 4676980 (1987-06-01), Segal et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4851341 (1989-07-01), Hopp et al.
patent: 5112952 (1992-05-01), Mallia et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5225539 (1993-07-01), Winter
patent: 5336603 (1994-08-01), Capon et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5770429 (1998-06-01), Lonberg et al.
patent: 5786180 (1998-07-01), Konig et al.
patent: 6114598 (2000-09-01), Kucherlapati et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: 6420113 (2002-07-01), Buechler et al.
patent: 6710226 (2004-03-01), Schenk
patent: 6743427 (2004-06-01), Schenk
patent: 6750324 (2004-06-01), Schenk et al.
patent: 6761888 (2004-07-01), Schenk
patent: 6787138 (2004-09-01), Schenk
patent: 6787139 (2004-09-01), Schenk
patent: 6787140 (2004-09-01), Schenk
patent: 6787143 (2004-09-01), Schenk
patent: 6787144 (2004-09-01), Schenk
patent: 6787523 (2004-09-01), Schenk
patent: 6787637 (2004-09-01), Schenk et al.
patent: 6808712 (2004-10-01), Schenk
patent: 6818218 (2004-11-01), Schenk
patent: 6866849 (2005-03-01), Schenk
patent: 6866850 (2005-03-01), Schenk
patent: 6870034 (2005-03-01), Breece et al.
patent: 6875434 (2005-04-01), Schenk
patent: 6890535 (2005-05-01), Schenk
patent: 6905686 (2005-06-01), Schenk
patent: 6913745 (2005-07-01), Schenk
patent: 6936246 (2005-08-01), Schenk
patent: 6946135 (2005-09-01), Schenk
patent: 6962707 (2005-11-01), Schenk
patent: 6972127 (2005-12-01), Schenk
patent: 6982084 (2006-01-01), Schenk
patent: 7014855 (2006-03-01), Schenk
patent: 7179892 (2007-02-01), Basi
patent: 7189819 (2007-03-01), Basi
patent: 7256273 (2007-08-01), Basi
patent: 7575880 (2009-08-01), Schenk et al.
patent: 7582733 (2009-09-01), Basi et al.
patent: 7588766 (2009-09-01), Schenk
patent: 7625560 (2009-12-01), Basi
patent: 7635473 (2009-12-01), Warne et al.
patent: 2003/0165496 (2003-09-01), Basi et al.
patent: 2004/0043418 (2004-03-01), Holtzman et al.
patent: 2004/0081657 (2004-04-01), Schenk
patent: 2004/0082762 (2004-04-01), Basi et al.
patent: 2004/0087777 (2004-05-01), Basi et al.
patent: 2004/0192898 (2004-09-01), Jia et al.
patent: 2004/0229330 (2004-11-01), Bettencourt et al.
patent: 2005/0013815 (2005-01-01), Schenk
patent: 2005/0019330 (2005-01-01), Schenk
patent: 2005/0059802 (2005-03-01), Schenk et al.
patent: 2005/0090648 (2005-04-01), Tsurushita et al.
patent: 2005/0107594 (2005-05-01), Sun et al.
patent: 2005/0118651 (2005-06-01), Basi et al.
patent: 2005/0142131 (2005-06-01), Hinton et al.
patent: 2005/0169925 (2005-08-01), Bardroff et al.
patent: 2005/0249723 (2005-11-01), Lazar
patent: 2006/0029611 (2006-02-01), Schenk
patent: 2006/0034858 (2006-02-01), Schenk
patent: 2006/0099206 (2006-05-01), Sinacore et al.
patent: 2006/0194953 (2006-08-01), Bonnerjea et al.
patent: 2006/0198851 (2006-09-01), Basi
patent: 2006/0210557 (2006-09-01), Luisi et al.
patent: 2007/0072307 (2007-03-01), Godavarti et al.
patent: 2007/0082367 (2007-04-01), Godavarti et al.
patent: 2007/0134762 (2007-06-01), Arumugham et al.
patent: 2007/0154480 (2007-07-01), Schenk et al.
patent: 2007/0161088 (2007-07-01), Arumugham et al.
patent: 2008/0096818 (2008-04-01), Schenk et al.
patent: 2008/0145373 (2008-06-01), Arumugham
patent: 2008/0221306 (2008-09-01), Basi
patent: 2008/0227718 (2008-09-01), Schenk
patent: 2008/0279873 (2008-11-01), Seubert
patent: 2008/0292625 (2008-11-01), Schroeter
patent: 2008/0299074 (2008-12-01), Arumugham
patent: 2009/0069544 (2009-03-01), Basi
patent: 2009/0142270 (2009-06-01), Schroeter et al.
patent: 2009/0155256 (2009-06-01), Black et al.
patent: 2009/0191231 (2009-07-01), Schenk
patent: 2009/0285806 (2009-11-01), Sinacore et al.
patent: 2009/0297511 (2009-12-01), Schenk
patent: 0125023 (1984-11-01), None
patent: 0323027 (1989-07-01), None
patent: 1601697 (2005-12-01), None
patent: WO-87/02671 (1987-05-01), None
patent: WO-93/08829 (1993-05-01), None
patent: WO-01/62801 (2001-08-01), None
patent: WO-02/46237 (2002-06-01), None
patent: WO-02/088306 (2002-11-01), None
patent: WO-02/088307 (2002-11-01), None
patent: WO-03/015691 (2003-02-01), None
patent: WO-03/016466 (2003-02-01), None
patent: WO-03/070760 (2003-08-01), None
patent: WO-03/077858 (2003-09-01), None
patent: WO-2004/080419 (2004-09-01), None
patent: WO-2004/108895 (2004-12-01), None
patent: WO-2006/066049 (2006-06-01), None
patent: WO-2006/066089 (2006-06-01), None
patent: WO-2006/066171 (2006-06-01), None
patent: WO-2006/138553 (2006-12-01), None
Amersham Biosciences, “Antibody Purification, Handbook,” retrieved online at www.chromatography.amershambiosciences.com (2002).
International Search Report for Application No. PCT/US2006/023478, dated Dec. 29, 2006.
International Preliminary Report on Patentability and Written Opinion for Application No. PCT/US2006/023478, dated Dec. 17, 2007.
Eliasson, Margareta et al, “Chimeric IgG-binding Receptors Engineered from Staphylococcal Protein A and Streptococcal Protein G,”The Journal of Biological Chemistry, vol. 263(9):4323-4327 (1988).
Hay, Beverly N. et al, “Bacteriophage cloning andEscherichia coliexpression of a human IgM Fab,”Hum. Antibod. Hybridomas, vol. 3:81-85 (1992).
Hoogenboom, Hennie R. et al, “Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains,”Nucleic Acids Research, vol. 19(15):4133-4137 (1991).
Liu, Alvin Y. et al, “Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells,”Proc. Natl. Acad. Sci. USA, vol. 84:3439-3443 (1987).
Milstein, C. et al, “Hybrid hybridomas and their use in immunohistochemistry,”Nature, vol. 305:537-540 (1983).
Oi, Vernon T. et al, “Chimeric Antibodies,”BioTechniques, vol. 4(3):214-221 (1986).
Sikkema, W. Dirk, “An Fc-binding protein,”Amer. Biotech. Lab., vol. 7:42 (1989).
Traunecker, André et al, “Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells,”The EMBO Journal, vol. 10(12):3655-3659 (1991).
“Chaotropism,” Stedman's Medical Dictionary, 27th Edition, Lippincott Williams and Wilkins (2000).
Amersham Biosciences, “Q Sepharose™ High Performance and SP Sepharose High Performance,” retrieved online at http://www4.gelifesciences.com/aptrix/upp00919.nsf/Content/WD:Q+Sepharose+Hig(1521788 76-R350) (2002).
Bales, K.R. et al, “Administration of an Anti-Aβ Fab Fragment to APPV717F Transgenic Mice Reduces Neuritic Plaque,”Therapeutics and Therapeutic Strategies, Poster Session P4-396, p. S587.
Bard, Frédérique et al, “Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology,”PNAS, vol. 100(4):2023-2028 (2003).
Bard, Frédérique et al, “Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease,”Nature Medicine, vol. 6(8):916-919 (2000).
Bussière, Thierry et al, “Morphological Characterization of Thioflavin-S-Positive Amyloid Plaques in Transgenic Alzheimer Mice and Effect of Passive Aβ Immunotherapy on Their Clearance,”American Journal of Pathology, vol. 165(3):987-995 (2004).
Bu
Godavarti Ranganathan
Iskra Timothy
Alston & Bird LLP
Janssen Alzheimer Immunotherapy
Saunders David A
Wyeth LLC
LandOfFree
Methods of purifying Fc region containing proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of purifying Fc region containing proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of purifying Fc region containing proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4195742